Brain Sci 13:1503 Arillotta D, Floresta G, Papanti Pelletier GD et al (2024) Exploring the potential impact of GLP-1 receptor agonists on substance use, compulsive behavior, and libido: insights from social media using a mixed-methods approach
Clinical trials have demonstrated greater weight loss with these higher doses compared to diabetes-indicated doses, with Wegovy producing average weight reductions of 12-15% of body weight
JAMA, 330 (20), 20002015
Measurable weight loss typically appears between days 10-21 of starting treatment, with initial losses of 1-3 pounds
Possible explanations for the association between ADHD and obesity include abnormal eating behaviors associated with ADHD, impulsivity leading to binge eating, or shared underlying neurobiological dysfunctions
Using the medication correctly and consistently is key to achieving and maintaining a healthy body weight